← Leaderboards

Scott L Letendre

University Of California, San Diego

Google Scholar ↗PubMed ↗ORCID ↗

$25,948,231

Attributed

$43,465,880

Total exposure

20

Grants

15

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.8M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$43,465,880 · 20

By mechanism

R01$26,620,515 · 7

R24$7,973,681 · 1

T32$2,431,779 · 1

R25$1,684,848 · 1

P30$1,472,496 · 4

K24$917,271 · 1

Top collaborators

Most similar at University Of California, San Diego

Same institution · by research overlap

Murray B. Stein$36,454,107
Brook Henry$8,903,411
Ronald J. Ellis$34,493,757
David J Moore$20,232,553
Arpi Minassian$3,527,634

Others in their field

Top investigators on “Performance”

Jeffrey P Krischer · University Of South Florida$413,069,911
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$378,749,497
Gary D Acton · University Of California-Davis$320,373,312
Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Lawrence Corey · Fred Hutchinson Cancer Center$319,618,139
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071

Research focus

PerformanceCohortNeurobehavioralParticipantAreaFundingResourcesProgramsAntiretroviral TherapyInflammationBiological MarkersAgingNeuroaidsPathogenesisLeadAcquired Immunodeficiency SyndromeNeurocognitiveBasePublic Health RelevanceBiologicalPersonsComorbidityNeuraxisSpecimen

Grant awards (89)

CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan$1,968,823

R24 · FY2025 · MH · contact PI

Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER$603,658

R01 · FY2025 · MH · contact PI

HOPE Training Grant$565,030

T32 · FY2025 · AI · contact PI

Sustained Training in Aging and HIV Research (STAHR)$209,974

R25 · FY2025 · MH · contact PI

Developmental Core$91,754

P30 · FY2025 · MH · contact PI

CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan$1,980,078

R24 · FY2024 · MH · contact PI

Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$751,792

R01 · FY2024 · AG

Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$710,942

R01 · FY2024 · DA · contact PI

Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER$710,186

R01 · FY2024 · MH · contact PI

HOPE Training Grant$515,425

T32 · FY2024 · AI · contact PI

Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER$122,093

R01 · FY2024 · MH · contact PI

Developmental Core$91,756

P30 · FY2024 · MH · contact PI

CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan$1,971,786

R24 · FY2023 · MH · contact PI

Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$783,353

R01 · FY2023 · AG

Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$710,942

R01 · FY2023 · DA · contact PI

Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER$710,186

R01 · FY2023 · MH · contact PI

HOPE Training Grant$461,039

T32 · FY2023 · AI · contact PI

Developmental Core$91,754

P30 · FY2023 · MH · contact PI

Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER$40,698

R01 · FY2023 · MH · contact PI

Sustained Training in Aging and HIV Research (STAHR)$1

R25 · FY2023 · MH · contact PI

CHARTER Plus: A resource for cutting-edge research on neurological function and mental health in people with HIV and substance use disorders across the lifespan$2,052,994

R24 · FY2022 · MH · contact PI

Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$815,809

R01 · FY2022 · AG

Identification of Biomarkers of CNS injury and resilience related to HIV-1 and Methamphetamine$711,920

R01 · FY2022 · DA

Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$710,942

R01 · FY2022 · DA · contact PI

Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER$710,186

R01 · FY2022 · MH · contact PI

HOPE Training Grant$413,119

T32 · FY2022 · AI · contact PI

Sustained Training in Aging and HIV Research (STAHR)$209,974

R25 · FY2022 · MH · contact PI

Developmental Core$91,754

P30 · FY2022 · MH · contact PI

SWG: HIV and Aging$35,695

P30 · FY2022 · AI · contact PI

Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$832,882

R01 · FY2021 · AG

Biopsychosocial Phenotypes and Potential Mechanisms in CHARTER$758,817

R01 · FY2021 · MH · contact PI

Identification of Biomarkers of CNS injury and resilience related to HIV-1 and Methamphetamine$715,475

R01 · FY2021 · DA

Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$623,855

R01 · FY2021 · DA · contact PI

HOPE Training Grant$477,166

T32 · FY2021 · AI · contact PI

Age related determinants of HAND: A 12 year follow-up of CHARTER participants$254,239

R01 · FY2021 · MH

Developmental Core$140,461

P30 · FY2021 · MH · contact PI

SWG: HIV and Aging$32,274

P30 · FY2021 · AI · contact PI

Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV$822,303

R01 · FY2020 · AG

Identification of Biomarkers of CNS injury and resilience related to HIV-1 and Methamphetamine$756,747

R01 · FY2020 · DA

Cannabis Effects on Antiretroviral Therapy, Pharmacokinetics, and Neurotoxicity$708,692

R01 · FY2020 · DA · contact PI

Developmental Core$295,299

P30 · FY2020 · MH · contact PI

Sustained Training in Aging and HIV Research (STAHR)$250,743

R25 · FY2020 · MH

Measurement of ART Drug Concentrations in Brain by 19F-MRS as an Indicator of Neurotoxicity$236,375

R21 · FY2020 · MH · contact PI

SWG: HIV and Aging$32,593

P30 · FY2020 · AI · contact PI

Age related determinants of HAND: A 12 year follow-up of CHARTER participants$1,502,802

R01 · FY2019 · MH

Identification of Biomarkers of CNS injury and resilience related to HIV-1 and Methamphetamine$712,228

R01 · FY2019 · DA

Sustained Training in Aging and HIV Research (STAHR)$250,743

R25 · FY2019 · MH

Developmental Core$202,868

P30 · FY2019 · MH · contact PI

Measurement of ART Drug Concentrations in Brain by 19F-MRS as an Indicator of Neurotoxicity$196,875

R21 · FY2019 · MH · contact PI

SWG: HIV and Aging$32,562

P30 · FY2019 · AI · contact PI

Age related determinants of HAND: A 12 year follow-up of CHARTER participants$1,504,147

R01 · FY2018 · MH

Identification of Biomarkers of CNS injury and resilience related to HIV-1 and Methamphetamine$764,642

R01 · FY2018 · DA

Sustained Training in Aging and HIV Research (STAHR)$268,614

R25 · FY2018 · MH

Developmental Core$83,812

P30 · FY2018 · MH · contact PI

SWG: HIV and Aging$82,331

P30 · FY2018 · AI · contact PI

Age related determinants of HAND: A 12 year follow-up of CHARTER participants$1,504,722

R01 · FY2017 · MH

Sustained Training in Aging and HIV Research (STAHR)$248,648

R25 · FY2017 · MH

Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research$182,619

K24 · FY2017 · MH · contact PI

Developmental Core$83,820

P30 · FY2017 · MH · contact PI

Age related determinants of HAND: A 12 year follow-up of CHARTER participants$1,506,029

R01 · FY2016 · MH

Sustained Training in Aging and HIV Research (STAHR)$246,151

R25 · FY2016 · MH

Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research$184,743

K24 · FY2016 · MH · contact PI

Developmental Core$83,762

P30 · FY2016 · MH · contact PI

Developmental Core$1

P30 · FY2016 · MH · contact PI

Age related determinants of HAND: A 12 year follow-up of CHARTER participants$1,585,664

R01 · FY2015 · MH

Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research$182,583

K24 · FY2015 · MH · contact PI

Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China$523,374

R01 · FY2014 · MH · contact PI

Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research$182,583

K24 · FY2014 · MH · contact PI

Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China$515,458

R01 · FY2013 · MH · contact PI

Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research$184,743

K24 · FY2013 · MH · contact PI

Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China$524,494

R01 · FY2012 · MH · contact PI

Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China$533,855

R01 · FY2011 · MH · contact PI

Milliplex FlexMAP 3D$152,979

S10 · FY2011 · RR · contact PI

Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China$135,847

R01 · FY2011 · MH · contact PI

Clinical Trial of CNS Penetrating ART to Prevent NeuroAIDS in China$566,532

R01 · FY2010 · MH · contact PI

Antiretroviral-Induced Immune Recovery and the Central Nervous System$231,750

R21 · FY2010 · MH · contact PI

Antiretroviral-Induced Immune Recovery and the Central Nervous System$193,125

R21 · FY2009 · MH · contact PI

BIOMARKERS$142,423

P01 · FY2009 · DA · contact PI

BIOMARKERS$127,943

P01 · FY2008 · DA · contact PI

BIOMARKERS$301,823

P01 · FY2007 · DA · contact PI

BIOMARKERS$169,769

P01 · FY2006 · DA · contact PI

BIOMARKERS$150,118

P01 · FY2005 · DA

Neurocognitive Effects of HCV, HIV, and Drug Use$425,650

R01 · FY2004 · DA

Neurocognitive Effects of HCV, HIV, and Drug Use$375,490

R01 · FY2003 · DA

MENTORED INVESTIGATION OF LEVELS OF CSF HIV RNA$140,405

K23 · FY2003 · MH

Neurocognitive Effects of HCV, HIV, and Drug Use$373,864

R01 · FY2002 · DA

MENTORED INVESTIGATION OF LEVELS OF CSF HIV RNA$107,235

K23 · FY2002 · MH

MENTORED INVESTIGATION OF LEVELS OF CSF HIV RNA$107,235

K23 · FY2001 · MH

MENTORED INVESTIGATION OF LEVELS OF CSF HIV RNA$107,235

K23 · FY2000 · MH